NewsView printer-friendly version
Coherus BioSciences Management to Present at the 41st Annual J.P. Morgan Healthcare Conference
Coherus is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer and the commercialization of our portfolio of FDA-approved therapeutics.
Coherus Contact Information:
SVP Investor Relations
Source: Coherus BioSciences, Inc.